Creative Medical Technology Holdings Inc
NASDAQ:CELZ

Watchlist Manager
Creative Medical Technology Holdings Inc Logo
Creative Medical Technology Holdings Inc
NASDAQ:CELZ
Watchlist
Price: 3.085 USD 5.65% Market Closed
Market Cap: 8m USD

Net Margin
Creative Medical Technology Holdings Inc

-43 500%
Current
-27 641%
Average
-6.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-43 500%
=
Net Income
-6.1m
/
Revenue
14k

Net Margin Across Competitors

Creative Medical Technology Holdings Inc
Glance View

Market Cap
8m USD
Industry
Biotechnology

Creative Medical Technologies, Inc. develops novel regenerative medicine and stem cell technologies. The company is headquartered in Phoenix, Arizona. The company went IPO on 2009-05-01. The firm conducts its commercial operations through its subsidiary, Creative Medical Technologies, Inc. (CMT). CMT markets and sells its CaverStem and FemCelz disposable kits utilized by physicians to perform autologous procedures that treat erectile dysfunction and female sexual dysfunction and female sexual dysfunction, respectively. The firm's products include CaverStem, FemCelz, StemSpine, Amniostem, ImmCelz and OvaStem. CaverStem utilizes a patient's own stem cells to treat erectile dysfunction (ED). FemCelz is used for the treatment and procedure for vaginal rejuvenation function.

CELZ Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-43 500%
=
Net Income
-6.1m
/
Revenue
14k
What is the Net Margin of Creative Medical Technology Holdings Inc?

Based on Creative Medical Technology Holdings Inc's most recent financial statements, the company has Net Margin of -43 500%.

Back to Top